Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
55
Participants
Timeline
Start Date
April 30, 2003
Primary Completion Date
May 31, 2005
Conditions
Extensive Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
Interventions
BIOLOGICAL
oblimersen sodium
Given IV
DRUG
carboplatin
Given IV
DRUG
etoposide
Given IV
Trial Locations (1)
60606
Cancer and Leukemia Group B, Chicago
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00042978 - Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter